| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |